A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo
Summary
Nature Biotechnology, Published online: 16 November 2026; doi:10.1038/s41587-026-03344-5 Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.
Description from Nature.
Who is covering this
-
A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo
Nature Biotechnology, Published online: 16 November 2026; doi:10.1038/s41587-026-03344-5 Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.
Comments
Comments need JavaScript.